|
|
||||||||




* Department of Chemistry, Lawrence University, Appleton, WI 54912; and
Department of Biomolecular Chemistry, University of Wisconsin, Madison, WI 53706
Viral respiratory infections are a major cause of asthma exacerbations and can contribute to the pathogenesis of asthma. Major group human rhinovirus enters cells by binding to the cell surface molecule ICAM-1 that is present on epithelial and monocytic lineage cells. The focus of the resulting viral infection is in bronchial epithelia. However, previous studies of the cytokine dysregulation that follows rhinovirus infection have implicated monocytic lineage cells in establishing the inflammatory environment even though productive infection is not a result. We have determined that human alveolar macrophages and human peripheral blood monocytes release MCP-1 upon exposure to human rhinovirus 16 (HRV16). Indeed, we have found p38 MAPK activation in human alveolar macrophages within 15 min of exposure to HRV16, and this activation lasts up to 1 h. The targets of p38 MAPK activation include transcriptional activators of the MCP-1 promoter. The transcription factor ATF-2, a p38 MAPK substrate, is phosphorylated 45 min after HRV16 exposure. Furthermore, I
B
, the inhibitor of the transcription factor NF-
B, is degraded. Prevention of HRV16 binding was effective in blocking p38 MAPK activation, ATF-2 phosphorylation, and MCP-1 release. This is the first report of a relationship between HRV16 exposure, MCP-1 release and monocytic-lineage cells suggesting that MCP-1 plays a role in establishing the inflammatory microenvironment initiated in the human airway upon exposure to rhinovirus.
This article has been cited by other articles:
![]() |
B G G Oliver, S Lim, P Wark, V Laza-Stanca, N King, J L Black, J K Burgess, M Roth, and S L Johnston Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages Thorax, June 1, 2008; 63(6): 519 - 525. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Thorley, P. A. Ford, M. A. Giembycz, P. Goldstraw, A. Young, and T. D. Tetley Differential Regulation of Cytokine Release and Leukocyte Migration by Lipopolysaccharide-Stimulated Primary Human Lung Alveolar Type II Epithelial Cells and Macrophages J. Immunol., January 1, 2007; 178(1): 463 - 473. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Korpi-Steiner, M. E. Bates, W.-M. Lee, D. J. Hall, and P. J. Bertics Human rhinovirus induces robust IP-10 release by monocytic cells, which is independent of viral replication but linked to type I interferon receptor ligation and STAT1 activation J. Leukoc. Biol., December 1, 2006; 80(6): 1364 - 1374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Butler, I. Robertson, C. M. Greene, S. J. O'Neill, C. C. Taggart, and N. G. McElvaney Elafin Prevents Lipopolysaccharide-induced AP-1 and NF-{kappa}B Activation via an Effect on the Ubiquitin-Proteasome Pathway J. Biol. Chem., November 17, 2006; 281(46): 34730 - 34735. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, C. Lau, S. Wiehler, A. Pow, T. Mazzulli, C. Gutierrez, D. Proud, and C.-W. Chow Syk Is Downstream of Intercellular Adhesion Molecule-1 and Mediates Human Rhinovirus Activation of p38 MAPK in Airway Epithelial Cells J. Immunol., November 15, 2006; 177(10): 6859 - 6870. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Ansari, N. Bhatnagar, O. Dittrich-Breiholz, M. Kracht, R. E. Schmidt, and H. Heiken Host chemokine (C-C motif) ligand-2 (CCL2) is differentially regulated in HIV type 1 (HIV-1)-infected individuals Int. Immunol., October 1, 2006; 18(10): 1443 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Laza-Stanca, L. A. Stanciu, S. D. Message, M. R. Edwards, J. E. Gern, and S. L. Johnston Rhinovirus Replication in Human Macrophages Induces NF-{kappa}B-Dependent Tumor Necrosis Factor Alpha Production. J. Virol., August 1, 2006; 80(16): 8248 - 8258. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Peng, S. Kotla, R. E. Bumgarner, and K. E. Gustin Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3. J. Virol., May 1, 2006; 80(10): 5021 - 5031. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |